Selected article for: "body weight and capsule formulation"

Title: 2015 ACVIM Forum Research Abstract Program
  • Document date: 2015_5_27
  • ID: 3pnuj5ru_766
    Snippet: Grapiprant in a capsule formulation was well tolerated when given for 28 days at serum exposures up to 4950 ng/mL. The aim of this study is comparing the pharmacokinetics of PDS dependent on body surface area (BSA) and body weight (BW) on small and large breed dogs......
    Document: Grapiprant in a capsule formulation was well tolerated when given for 28 days at serum exposures up to 4950 ng/mL. The aim of this study is comparing the pharmacokinetics of PDS dependent on body surface area (BSA) and body weight (BW) on small and large breed dogs.

    Search related documents:
    Co phrase search for related documents